SecBot SecBot
PRESS-RELEASE ·Filed Apr 24, 2026

ALVO

Alvotech
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

Traders should monitor the May 6 earnings release and May 7 call for updates on revenue, R&D progress, and commercial performance of Alvotech’s biosimilar pipeline. The lack of pre-disclosed data means volatility is likely to be driven by actual results and management commentary during the call.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
ALVO ▲ +4.14% at T+60d
NEUTRAL call +4.14% · α vs SPY -0.94% · entry $3.38 → $3.52
Entry = T+0 close
Apr 24, 2026
via day close
T+1d
-2.37%
call -2.37% · α -2.53%
$3.30
settled 6mo ago
T+5d
-1.18%
call -1.18% · α -2.09%
$3.34
settled 6mo ago
T+20d
0.00%
call 0.00% · α -4.03%
$3.38
settled 5mo ago
T+60d
+4.14%
call +4.14% · α -0.94%
$3.52
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Alvotech announced it will release its Q1 2026 financial results on May 6, 2026, followed by a webcast and live Q&A on May 7, 2026. The press release is purely logistical, confirming the earnings date and call details without disclosing any financial data or updates. This type of announcement is routine and provides no new material information.

Key Facts

  • Alvotech will release Q1 2026 financial results on May 6, 2026, after market close.
  • A webcast with live Q&A is scheduled for May 7, 2026, at 08:00 EST.
  • No financial results, guidance updates, or operational developments were disclosed in this release.
  • The announcement serves only to communicate timing and access details for the upcoming earnings call.

Financial Impact

None disclosed — this is a scheduling announcement only.

Risk Factors

  • Potential for negative earnings surprise or weak guidance during the upcoming call.
  • Lack of near-term catalysts outside of earnings, which may lead to investor sentiment fatigue.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3280780
28 reports for ALVO
Performance horizon
80% Hit rate @ T+20 12 of 15 directional calls Went positive at some point 18 of 19 best @ T+60▲ +60.61%Jul 1, 2026
Filters
Rows
Reports for ALVO — sortable, filterable
TypeNow
Oct 20, 2026
7d ago
6-K
BULLISH ★ 6/10
$5.12awaiting T+20—$4.64 (−9.47%)
Oct 14, 2026
12d ago
6-K
BULLISH ★ 7/10
$5.17awaiting T+20—$4.64 (−10.35%)
Oct 7, 2026
19d ago
6-K
NEUTRAL ★ 4/10
$5.85awaiting T+20—$4.64 (−20.77%)
Oct 5, 2026
22d ago
6-K
BULLISH ★ 6/10
$6.11awaiting T+20—$4.64 (−24.14%)
Oct 5, 2026
22d ago
Press Release
BULLISH ★ 7/10
$6.11awaiting T+20—$4.64 (−24.14%)
Aug 31, 2026
8w ago
6-K
BULLISH ★ 7/10
$5.19 $5.92▲ +14.07%▲ +14.44%$4.64 (−10.69%)
Aug 21, 2026
9w ago
6-K
BULLISH ★ 7/10
$4.43 $5.88▲ +32.73%▲ +31.72%$4.64 (+4.63%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 6/10
$4.27 $5.87▼ −37.47%▼ −37.59%$4.64 (−8.55%)
Jul 29, 2026
12w ago
6-K
BULLISH ★ 7/10
$3.53 $4.91▲ +39.09%▲ +34.07%$4.64 (+31.30%)
Jul 3, 2026
16w ago
Press Release
NEUTRAL ★ 4/10
$3.46 $4.12▲ +19.08%▲ +19.64%$4.64 (+33.96%)
Showing 10 of 28

US Market Status

Market Open — Closes in 6h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 24, 2026